Elaheh Farahani; Mozhdeh Haddadi
Acute coronavirus syndrome (SARS-CoV-2) leads to the COVID-19 epidemic. In accordance with the WHO, the epidemic remains a serious danger to the general health because of its global ...
Acute coronavirus syndrome (SARS-CoV-2) leads to the COVID-19 epidemic. In accordance with the WHO, the epidemic remains a serious danger to the general health because of its global spread and higher transmission rates. A scope of measures is needed to slow the spread of the epidemic and save lives, including the continuous assessment and cautious adjustment of general health reactions to the medical treatment. In such a manner, the expansion of antiviral nanostructures by improved surface designing may be valuable in combating this new virus. Quantum dots are multifaceted agents with the potency to fight or prevent the activity of the Coronavirus. For qualitative diagnosis, a simple and inexpensive bioassay method based on Fluorescence-based QDs nanoparticles can be used to detect SARS-CoV-2 antibodies. Optimization of quantum dots with effective functional molecules against SARS-CoV-2 could extend the nanostructures to the antiviral treatment and eradicate future epidemics, slowing down and possibly ending the spread of viral infections. QDs can be used to promote individual clinical therapy in the future based on each patient's molecular protocols individually. This study addresses how quantum dots (QDs) are useful in diagnosing SARS-CoV-2 infection and future pandemics.